Literature DB >> 3257999

Characterization of the mononuclear infiltrate in basal cell carcinoma: a predominantly T cell-mediated immune response with minor participation of Leu-7+ (natural killer) cells and Leu-14+ (B) cells.

J M Habets1, B Tank, V D Vuzevski, E C van Reede, E Stolz, T van Joost.   

Abstract

We investigated the peritumoral inflammatory infiltrate in 22 basal cell carcinoma (BCC) from 18 patients using a series of monoclonal antibodies. In all the 22 BCC the infiltrate consisted mainly of T cells (55 +/- 15%) and only in three cases an invasion of the tumor nests by these cells was observed. The T helper (TH) subset predominated over the T suppressor/cytotoxic (TS/C) subset (TH/TS/C ratio of 1.9 +/- 0.8). In 8 of 22 BCC mild infiltrate was observed with 48 +/- 13% T cells and a TH/TS/C ratio of 1.5 +/- 0.6. In 14 of 22 BCC moderate to heavy infiltrate with 59 +/- 15% T cells and a TH/TS/C ratio of 2.0 +/- 1.0 was observed. There was a significant difference in the percentage of T cells in BCC with moderate to heavy infiltrate and that in BCC with mild infiltration. The mean percentage of HLA-DR+ cells was 54 +/- 11%; Langerhans cells (LC) 4 +/- 5%; and Leu-M5+ (monocytes and macrophages) 16 +/- 11%. Less than 2% Leu-14+(B) cells were seen in the infiltrate. The mean percentage of Leu-7+ (natural killer) cells was 4 +/- 4%, and only 1 of 22 BCC Leu-7+ cells invaded tumor nests, contacting with tumor cells. From these results we concluded that T cells play a major role in the defence against BCC proliferation. The main role of Langerhans cells and Leu-M5+ cells may be that of antigen presentation. B cells and NK cells probably play a minor role in the local defence against BCC proliferation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257999     DOI: 10.1111/1523-1747.ep12456065

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

1.  Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon.

Authors:  N Mozzanica; A Cattaneo; V Boneschi; L Brambilla; E Melotti; A F Finzi
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Characterization of the mononuclear infiltrate in Bowen's disease (squamous cell carcinoma in situ). Evidence for a T cell-mediated anti-tumour immune response.

Authors:  J M Habets; B Tank; T van Joost
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

3.  Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and Therapy Monitoring.

Authors:  Amanda Bulman; Monica Neagu; Carolina Constantin
Journal:  Curr Proteomics       Date:  2013-09       Impact factor: 0.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.